Annual Reports
HCCI’s Health Care Cost and Utilization Reports

Yearly reviews of spending, price and utilization trends for commercially-insured Americans. Learn more about our methodology, definitions, and other resources.

Jul
20

USA Today: Fact check: False claim that COVID-19 vaccine isn't effective because you're not charged for it

HCCI's research on insulin prices was featured in a USA Today article on COVID-19 vaccine misinformation.  From the article: "Insulin prices nearly doubled in the U.S from 2012 to 2016, a 2019 report by the nonprofit Health Care Cost Institute found." Fact check: False claim links COVID-19 vaccine's price, effectiveness Even though almost all COVID-19 deaths are occurring among unvaccinated p...

Continue reading
Jul
09

News Nation USA: Effort to Decipher Hospital Prices Yields Key Finding: Don't Try It at Home

HCCI's created a list of most common outpatient procedures used in an article on the difficulty of using hospital price transparency data.  Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home - News Nation USA A federal price transparency rule that took effect this year was supposed to give patients, employers and insurers a clearer picture of the true cost of https://...

Continue reading
Tags:
Jul
04

AJPM: Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use

 Introduction This study assesses the associations between the recent implementation of robust features of state Prescription Drug Monitoring Programs and the abrupt discontinuation of long-term opioid therapies. Methods Data were from a national commercial insurance database and included privately insured adults aged 18–64 years and Medicare Advantage enrollees aged ≥65 years who initiated a...

Continue reading
Jun
29

USA Today: Walmart launching its own low-cost insulin to 'revolutionize' affordability for diabetics

HCCI's research on insulin prices was featured in USA Today. From the article: "The lower-cost insulin is being released by Walmart in response to surging costs for the treatment used for patients with diabetes. According to the Health Care Cost Institute, a non-profit organization which sheds light on health care spending, the average price for an insulin prescription nearly doubled from 2012 ($3...

Continue reading
Tags:
Jun
29

CNBC: Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drug

HCCI's research on the price of insulin was featured in CNBC.  From the article: "As the number of people with diabetes climbs, the cost of the 100-year-old drug has soared rather than fallen and drawn scrutiny from lawmakers. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from $2,900 in 2012 to $5,700 in 2016, according to the most recent data available...

Continue reading
Tags: